Hanall Biopharma is one of the most frequently mentioned Korean drugmakers when analysts forecast the arrival of a global blockbuster drug. In developing autoimmune disease treatment candidate HL161(batoclimab), there are many ongoing clinical trials of batoclimab by partners in the U.S. and China t
Korea's drug regulators have recently notified that tofacitinib, baricitinib, and upadacitinib, used for treating rheumatoid arthritis, could increase the risk of heart-related severe events.The Ministry of Food and Drug Safety (MFDS) sent out letters about the increased risk of Pfizer's Xeljanz (in
Korea has emerged as a "technology powerhouse" as the nation is seeing new innovative startups that are working on visualizing the once futuristic technology to real life. Korea Biomedical Review met with innovative CEOs from various healthcare startups to hear about their company and what they beli
The government announced that it would extend the current social distancing scheme implemented nationwide until Oct. 3, but ease the some measures after facing fierce backlash from small-business owners.From next week, private gatherings of up to six people, including four people who have completed
The nation’s public health insurance assessment organ has decided to provide conditional reimbursement for Xospata (ingredient: gilteritinib) in treating leukemia patients.The Health Insurance Review and Assessment Service (HIRA) reviewed whether it is appropriate to cover health insurance for Xospa
A compound injection of acetaminophen plus ibuprofen recently received regulatory approval in Korea on Monday, marking the first landing of a unique double-action formulation for fast and effective pain relief.The Ministry of Food and Drug Safety (MFDS) approved KB Pharm to supply Maxigesic, the com
Takeda is strengthening its position in the anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) first-line treatment market with Alunbrig, armed with new data showing the drug’s superiority compared to other treatments.“If I had to choose just one, I would choose Alunbrig (I
Astellas Korea’s Xospata 40mg (gilteritinib fumarate), a treatment for acute myeloid leukemia (AML), has taken a step closer to winning health insurance benefits.On Friday, the Health Insurance Review and Assessment Service (HIRA) released the result of the drugs benefit appraisal committee’s meetin
The number of clinical trials to confirm the safety and efficacy of software medical devices is increasing steadily, government data showed.The trend reflects the recognition of software medical devices as the key technology to meet a new demand in healthcare where physicians’ focus of patient care
Cellid released the results of a phase 2a trial of Covid-19 vaccine candidate AdCLD-CoV19.The company disclosed cases of the adverse events partially and said the middle dose group and the high dose group did not demonstrate a statistically significant difference in neutralizing antibody titer.The c
The public health authorities have concluded that the Covid-19 vaccines have no links to recently reported cases of acute leukemia, citing the opinions of hematological experts.Health officials said it is unnecessary to worry about leukemia after receiving the Covid-19 vaccine and recommended people
Samyang Biopharmaceuticals' U.S. subsidiary, Samyang Biopharm USA, is pushing to develop its cancer immunotherapy drug candidate, SYB-010, through global open innovation.Samyang Biopharm USA recently signed an agreement with the Spanish National Research Council, the largest public research institut
Researchers at Bundang CHA Hospital and Chaum Life Center have found a relationship between urine organic acids and metabolic syndrome.“It is often difficult for people with metabolic syndrome to know which metabolic problem they have,” the hospital said.Therefore, the team -- led by Professors Ham
Covid-19 survivors can develop sufficient antibodies by receiving a single dose of a Covid-19 vaccine, a Korean study showed.According to the study, people who recovered from Covid-19 infection could enjoy a full protection effect with only one-time vaccination.The study could back up a proposal tha
The first CAR-T therapy, Kymriah (ingredient: tisagenlecleucel), failed to pass the review of a panel at the Health Insurance Review and Assessment Service (HIRA) due to its hefty price tag of 500 million won ($430,884).According to an official at HIRA, the agency’s cancer drugs benefit appraisal co
HLB said the company would present the two interim results of combination treatment of its rivoceranib with immune-oncology and cytotoxic antineoplastic drugs at the online World Conference on Lung Cancer (WCLC) 2021 on Sept. 13.The clinical results showed a 40 percent overall response rate (ORR), 9
Researchers at the Korea Institute of Science and Technology (KIST) have developed an artificial intelligence technology that generates computed tomography based on magnetic resonance imaging images.The team, led by Doctor Kim Hyung-min of the Bionics Research Center at KIST, hopes that the technolo
Hanall Biopharma said its Chinese partner, Harbour BioMed, has received approval from China's National Medical Products Administration (NMPA) to conduct a phase 2 clinical trial of HL161 for chronic inflammatory demyelinating polyneuropathy.Harbour BioMed signed an agreement with Hanall Biopharma in
Voronoi said that it has licensed out its autoimmune disease treatment program to Brickell Biotech.Under the accord, Voronoi will receive a down payment of $5 million and can receive up to $323.5 million depending on the development progress of the treatment candidate.The candidate inhibits the diff
Pfizer Korea said Thursday that the Ministry of Health and Welfare would begin to reimburse Somavert, its acromegaly treatment, from this month.According to the current standard, the health authorities reimburse Somarvert to patients over 18 with acromegaly who have received surgery and radiation th